Modern Diagnostic & Research Centre Share Price Today | Stock Price & Modern Diagnostic & Research Centre Share Screener
Track the current Modern Diagnostic & Research Centre share price and stock price live with TickJournal's free stock screener. Check Modern Diagnostic & Research C 52-week for the annual price range and momentum. Use the Modern Diagnostic & Research Centre stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Modern Diagnostic & Research Centre opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Modern Diagnostic & Research Centre Share Price Chart
Track the current stock price of Modern Diagnostic & Research Centre with an interactive chart. Analyse MDRC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Modern Diagnostic & Research Centre stock quote in one place.
Modern Diagnostic & Research Centre Company Profile - Fundamental Screener
Screen Modern Diagnostic & Research Centre company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for MDRC shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Healthcare Service Provider industry, and it trades under ISIN INE1HK501016.
Company Details
Classification
Identifiers and Leadership
Modern Diagnostic & Research Centre Balance Sheet Screener
Screen MDRC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹119, up from ₹65 in 2025.
Latest statistics put total assets at ₹119 and shareholder funds at ₹59, with a leverage ratio of 0.75.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 119 | 65 | 50 | 37 | 49 |
| Current Assets | 43 | 25 | 18 | 12 | 18 |
| Fixed Assets | 48 | 31 | 27 | 24 | 24 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 17 | 12 | 14 | 9 | 17 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 59 | 21 | 12 | 6 | 12 |
| Share Capital | 15 | 11 | 1 | 1 | 1 |
| Reserves & Surplus | 43 | 10 | 11 | 5 | 11 |
Modern Diagnostic & Research Centre Income Statement Screener - Profit & Revenue Analysis
Screen Modern Diagnostic & Research Centre income statement and profit fundamentals. Analyze MDRC quarterly results. Modern Diagnostic & Research Centre reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹84 and net profit of ₹5.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||
| Revenue | 0 | 84 | 79 | 69 | 57 | 61 |
| Expenses | 0 | 71 | 60 | 56 | 57 | 54 |
Operating Costs and Margins | ||||||
| EBITDA | 0 | 14 | 19 | 13 | -1 | 6 |
| Operating Profit % | 0.00% | 15.00% | 23.00% | 16.00% | -2.00% | 10.00% |
| Depreciation | 0 | 5 | 4 | 4 | 4 | 4 |
| Interest | 0 | 2 | 2 | 2 | 1 | 2 |
Profit and Earnings | ||||||
| Profit Before Tax | 0 | 6 | 13 | 7 | -6 | 1 |
| Tax | 0 | 1 | 4 | 1 | 0 | 3 |
| Net Profit | 0 | 5 | 9 | 6 | -6 | -2 |
| EPS | 0.00 | 3.48 | 8.19 | 5.27 | -5.21 | -1.32 |
Modern Diagnostic & Research Centre Cash Flow Screener - Liquidity Fundamentals
Screen MDRC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹4, and net cash flow was an inflow of ₹9.
Over the same period, investing activities used ₹40 and financing activities provided ₹45.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|
Cash from Operations and Investing | |||||
| Operating Activities | 4 | 14 | 8 | 0 | 4 |
| Investing Activities | -40 | -13 | -11 | 2 | -5 |
Financing and Net Cash | |||||
| Financing Activities | 45 | 0 | 3 | -7 | 5 |
| Net Cash Flow | 9 | 0 | 0 | -5 | 3 |
Modern Diagnostic & Research Centre Shareholding Pattern Screener
See Modern Diagnostic & Research Centre shareholding pattern with promoter, FII, and DII holdings. Check Modern Diagnostic & Research Centre promoter holding and ownership changes for MDRC on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jan, promoters held 72.85%, foreign institutions 1.07%, domestic institutions 11.80% and the public 12.82%, spread across 641 shareholders.
The shareholder count was 641 in 2026-Jan, compared with 282 in 2026-Mar.
| Item | 2026-Jan | 2026-Mar | 2025-Mar | 2025-Dec | 1899-Dec |
|---|---|---|---|---|---|
Promoter Holding | |||||
| Promoter Holding | 72.85% | 72.85% | 100.00% | 100.00% | 72.85% |
Institutional Investors | |||||
| FII Holding | 1.07% | 0.03% | 0.00% | 0.00% | 1.07% |
| DII Holding | 11.80% | 15.48% | 0.00% | 0.00% | 11.80% |
Government, Public and Others | |||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.82% | 4.75% | 0.00% | 0.00% | 12.82% |
| Other Holding | 1.45% | 6.89% | 0.00% | 0.00% | 1.46% |
| Shareholder Count | 641 | 282 | 7 | 7 | 641 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Modern Diagnostic & Research Centre. Modern Diagnostic & Research Centre dividend yield can be compared with peers and other stocks in the market.
Modern Diagnostic & Research Centre Stock Index Membership - Nifty & Sensex
See which indices include Modern Diagnostic & Research Centre stock. Check MDRC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Modern Diagnostic & Research Centre Market Events Screener - Corporate Actions
Get Modern Diagnostic & Research Centre corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Modern Diagnostic & Research Centre stock events that may affect MDRC share price, along with derivatives, futures and options activity and sector gainers.
2 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | 41.21% |
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | -1.46% |
Modern Diagnostic & Research Centre Competitors Screener - Peer Stocks Comparison
Screen MDRC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 32,373 | 60.10 | 2,864 | 12.11% | 510 | 58.55 |
| Vijaya Diagnostic Centre | 14,937 | 81.17 | 835 | 19.34% | 173 | 47.24 |
| Metropolis Healthcare | 11,342 | 57.53 | 1,671 | 24.15% | 191 | 40.73 |
| Thyrocare Technologies | 8,643 | 49.47 | 846 | 20.48% | 163 | 40.51 |
| Nephrocare Health Services | 6,691 | 78.39 | 1,023 | 32.93% | 77 | 35.51 |
| Suraksha Diagnostic | 1,844 | 52.79 | 314 | 22.55% | 31 | 65.77 |
| Krsnaa Diagnostics | 1,789 | 18.47 | 816 | 9.90% | 101 | 50.95 |
| 3B BlackBio DX | 1,462 | 24.79 | 142 | 27.17% | 61 | 68.55 |
| One Global Service Provider | 1,030 | 14.13 | 499 | 237.48% | 70 | 45.89 |
| Health X Platform | 913 | -34.91 | 1,378 | 17.65% | -1 | 37.93 |
Modern Diagnostic & Research Centre Company Announcements - News & Reports Screener
Screen MDRC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 4, 2026.
The next most recent announcements are dated September 15, 2026 and September 15, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-04 | Closure of Trading Window | - |
| 2026-09-15 | Clarification On Significant Movement In The Price Of The Securities Of The Company | - |
| 2026-09-15 | Clarification sought from Modern Diagnostic & Research Centre Ltd | - |
| 2026-09-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-05 | Revised Letter Attached In The Intimation For 14Th AGM Of The Company | - |
| 2026-09-05 | Revised Date In The Letter Attached For Intimation Of Book Closure | - |
| 2026-09-05 | Revised Date In The Letter Attached For Intimation Of Record Date | - |
| 2026-09-03 | Intimation For The 14Th Annual General Meeting (AGM) And Book Closure | - |
| 2026-09-03 | Intimation For The 14Th Annual General Meeting (AGM) And Book Closure | - |
| 2026-09-03 | Intimation For Record Date | - |
| 2026-09-03 | Intimation Of Appointment Of Scrutinizer Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (LODR) | - |
| 2026-09-03 | Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-26 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-05-29 | Financial Results For The Half Year And Year Ended 31.03.2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-05-28 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-21 | Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015 | - |
| 2026-05-21 | Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Year Ended 31St March 2026 | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 1.77. Market capitalisation stands at ₹110.19 Cr. The company operates in the Healthcare sector, in the Healthcare Service Provider industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 5, 2026. This page covers 5 balance sheet periods, 6 income statement periods, 5 cash flow years and 5 shareholding periods. Information is provided for research and is not investment advice.